1 9 o c t o b e r 2 0 1 7 | V o L 5 5 0 | N A t U r e | 4 1 5 Letter Transient receptor potential mucolipin 1 (TRPML1) is a cation channel located within endosomal and lysosomal membranes. Ubiquitously expressed in mammalian cells 1,2 , its loss-offunction mutations are the direct cause of type IV mucolipidosis, an autosomal recessive lysosomal storage disease 3-6 . Here we present the single-particle electron cryo-microscopy structure of the mouse TRPML1 channel embedded in nanodiscs. Combined with mutagenesis analysis, the TRPML1 structure reveals that phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P 2 ) binds to the N terminus of the channel-distal from the pore-and the helixturn-helix extension between segments S2 and S3 probably couples ligand binding to pore opening. The tightly packed selectivity filter contains multiple ion-binding sites, and the conserved acidic residues form the luminal Ca 2+ -blocking site that confers luminal pH and Ca 2+ modulation on channel conductance. A luminal linker domain forms a fenestrated canopy atop the channel, providing several luminal ion passages to the pore and creating a negative electrostatic trap, with a preference for divalent cations, at the luminal entrance. The structure also reveals two equally distributed S4-S5 linker conformations in the closed channel, suggesting an S4-S5 linker-mediated PtdInsP 2 gating mechanism among TRPML channels 7,8 .
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Structure of mammalian endolysosomal TRPML1 channel in nanodiscs
Qingfeng chen 1,2,3 *, Ji She 1,2 *, Weizhong Zeng 1,2,3 , Jiangtao Guo 1,2 , Haoxing Xu 4 , Xiao-chen bai 2 & Youxing Jiang 1, 2, 3 Transient receptor potential mucolipin 1 (TRPML1) is a cation channel located within endosomal and lysosomal membranes. Ubiquitously expressed in mammalian cells 1,2 , its loss-offunction mutations are the direct cause of type IV mucolipidosis, an autosomal recessive lysosomal storage disease [3] [4] [5] [6] . Here we present the single-particle electron cryo-microscopy structure of the mouse TRPML1 channel embedded in nanodiscs. Combined with mutagenesis analysis, the TRPML1 structure reveals that phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P 2 ) binds to the N terminus of the channel-distal from the pore-and the helixturn-helix extension between segments S2 and S3 probably couples ligand binding to pore opening. The tightly packed selectivity filter contains multiple ion-binding sites, and the conserved acidic residues form the luminal Ca 2+ -blocking site that confers luminal pH and Ca 2+ modulation on channel conductance. A luminal linker domain forms a fenestrated canopy atop the channel, providing several luminal ion passages to the pore and creating a negative electrostatic trap, with a preference for divalent cations, at the luminal entrance. The structure also reveals two equally distributed S4-S5 linker conformations in the closed channel, suggesting an S4-S5 linker-mediated PtdInsP 2 gating mechanism among TRPML channels 7, 8 .
The mucolipin subfamily of transient receptor potential (TRPML) channels are predominantly localized in the membranes of the late endosomes and lysosomes 1, 2 . Among the three isoforms of TRPML channels (TRPML1-3), TRPML1 is ubiquitously expressed in mammalian cells and has been the subject of extensive study 2, [9] [10] [11] [12] [13] [14] . TRPML1 is a Ca 2+ -permeable, non-selective, six-transmembrane tetrameric cation channel, which is thought to be the main lysosomal Ca 2+ -release channel and is of importance in lysosomal trafficking and signal transduction [15] [16] [17] [18] [19] . Like most TRP channels, TRPML1 is ligand-gated and can be activated by the endolysosomal-specific lipid phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P 2 ) 7,8 , whereas it is inhibited by the plasma membrane-localized phosphoinositide isoform PtdIns(4,5)P 2 14 (Extended Data Fig. 1 ). This lipid-isoform-dependent gating property defines the compartment-specific channel activity of TRPML1. In humans, loss-of-function mutations in TRPML1 are the direct cause of mucolipidosis type IV, an autosomal recessive lysosomal storage disease characterized by abnormal neurodevelopment, retinal degeneration and iron-deficiency anaemia [3] [4] [5] [6] . Owing to its direct link to this disease, TRPML1 has been a potential target for small-molecule therapeutic agents, and several synthetic small-molecule agonists have been developed 12, 20 .
We purified and reconstituted mouse TRPML1 into nanodiscs and determined its structure using single-particle electron cryo-microscopy (cryo-EM) to a resolution of 3.59 Å, using the 'gold standard' Fourier shell correlation (FSC) = 0.143 criterion 21 (Extended Data Figs 2-4 and Methods). The cryo-EM density map is of sufficient quality to build models of major parts of the protein (Extended Data Figs 5 and 6). TRPML1 consists of two structural components: the membranespanning S1-S6 region embedded in a nanodisc, and the luminal S1-S2 linker that forms a fenestrated canopy atop the channel domain ( Fig. 1 ). Like other classical six-transmembrane tetrameric cation channels, the S1-S6 of each subunit is separated into an S1-S4 voltage-sensing domain and an S5-S6 pore domain, linked by the S4-S5 linker helix. The tetramer assembly is domain-swapped, with the S1-S4 domain interacting with the pore-forming S5-S6 of a neighbouring subunit. As the structure was determined in a lipid environment, a density of poly-acyl chains from closely attached lipid molecules is clearly visible within the grooves between two neighbouring S1-S4 domains ( Fig. 1a ). The 200-residue, luminal-facing linker domain between S1 and S2 can self-assemble into a tetramer and its crystal structure 22 fits readily into our electron microscopy density map, facilitating our model building. Asn230 of the luminal linker domain is glycosylated with visible electron density for the covalently linked N-acetylglucosamine moiety of the sugar (Fig. 1b, c) .
The S1-S4 domain of TRPML1 is similar to that of other TRP channels, but differs from the canonical voltage-sensing domain of voltagegated channels ( Fig. 2a ). It consists of four straight helices tightly packed against each other. Lacking the canonical voltage-sensing arginine residues, the S4 helix runs antiparallel to the S5 helix of a neighbouring subunit and exhibits extensive hydrophobic interactions ( Fig. 2a ). The S1-S4 domain of TRPML probably remains static, similar to TRPV1 23, 24 , and does not undergo any conformational change during channel gating. There are two cytosolic extensions to the S1-S4 domain that are unique to TRPML channels ( Fig. 2a, b ). First, an Arg/Lys-rich (poly-basic) domain from residues 40 to 62 forms two short clamp-shaped helices, labelled as H1 and H2, right before S1. Second, the linker between S2 and S3 forms a helix-turn-helix (H3-turn-H4) that extends into the cytosol and also makes direct contact with the N-terminal H1 helix (Fig. 2b ). The N-terminal poly-basic domain is important for PtdInsP 2 binding 7,14 , and its deletion abolishes PtdIns(3,5)P 2 activation of TRPML1 (Extended Data Fig. 1e ). The H1 and H2 helices of the poly-basic domain, along with the N terminus of S1, create a positively charged pocket directly beneath the cytosolic membrane surface (Fig. 2b) , which is likely to accommodate the inositol trisphosphate head group of membrane-anchored PtdInsP 2 . Because the PtdInsP 2 site is distant from the inner helix-formed channel gate, we consider that PtdInsP 2 activation is mediated by the H3-turn-H4 extension, in which the H3 helix interacts with the H1 and the H4 helix interacts with the S4-S5 linker in a specific conformation, as will be discussed later.
Because the structure was determined in the absence of ligands, the TRPML1 ion conduction pore, consisting of the S5, S6 and two pore helices (P1 and P2), adopts the closed conformation ( Fig. 3a, b ). The four pore-lining S6 inner helices form a bundle crossing at the cytosolic side with multiple narrow constriction points that prevent the passage of hydrated cations. Surrounding the cytosolic gate, S6 makes tight contact with the N-terminal region of S5 ( Fig. 3a , inset), suggesting a coupled movement between S5 and S6 upon channel gating. The Phe, Ile, Tyr, Met and Val residues on S6, just below the selectivity filter region, form a π-helix ( Fig. 3a) , a structural feature that has also been observed in other TRP channel structures 23, 25 and may facilitate the bending of the S6 inner helix for channel gating.
The TRPML1 selectivity filter has the sequence 469 Asn-Gly-Asp-Asp-Met and adopts a multi-ion configuration (Fig. 3c ). The backbone carbonyls of the Asn-Gly-Asp residues all point towards the central | Structure of the S1-S4 region and the PtdInsP 2 -binding site. a, Right, S1-S4 domain (blue) of the front subunit. The two cytosolic extensions are coloured differently: magenta for H1 and H2 and green for the H3-turn-H4 between S2 and S3. The inset (left) shows inter-subunit contact between the S4 helix (blue) and the neighbouring S5 (pink). b, Expanded view of the poly-basic domain and the interactions between the H1 and H3 helices. pore axis, creating two contiguous ion-binding cages (labelled as S1 and S2)-reminiscent of the two K + channel sites but with wider dimensions-and probably accommodating partially dehydrated cations. The second Asp (Asp472), the carboxylate side chain of which is pointed upright, is stabilized laterally by a salt bridge with a highly conserved Lys453 between the S5 and P1 helices. Four Asp472 residues in a channel tetramer encircle an ion-binding site (labelled as S0) at the luminal entrance of the channel, where an electron density peak is clearly visible and was modelled as Na + , the only cation in the sample (Fig. 3c ). The distance between the S0 ion and the carboxylate oxygen of Asp472 is about 5 Å, and the ion chelation is likely to be mediated by water. TRPML1 is known to be Ca 2+ permeable, and Ca 2+ permeation lowers channel conductance by blocking monovalent cation currents in a luminal-pH-dependent manner (Extended Data Fig. 7a ). Surrounded by acidic residues, we propose that S0 is the Ca 2+ blockage site. Indeed, neutralizing Asp472 with Asn results in a markedly diminished luminal Ca 2+ block (Extended Data Fig. 7b , c).
The TRPML1 filter is rigidly held in place by two pore helices with tightly packed surroundings. The side-chain carboxylate of Asp471 has an essential role in stabilizing the filter conformation, by generating a hydrogen-bonding network with the backbone amide nitrogen atoms of the neighbouring filter residues (Fig. 3d ). The Met473 side chain is extended parallel to the filter and fills the surrounding void (Fig. 3c ). The tight packing of the TRPML1 filter is quite different from that of the TRPV1 filter, in which the equivalent P2 helix is replaced by an extended loop, allowing the filter to undergo a marked conformational change upon binding of spider vanillotoxin and gating 24 . A similar filter conformational change is unlikely to occur in TRPML1.
The four luminal linker domains, each consisting of two long helices and seven strands, form a square-shaped canopy with a central opening above the channel pore (Figs 1b and 3e ), a characteristic feature of group 2 TRP channels including TRPML and TRPP 25, 26 (Extended Data Fig. 8 ). The α1 and α2 helices, along with the long downward-facing loop (the luminal pore loop) between them, generate a funnel-shaped hole at the centre of the canopy. The tip of the luminal pore loop is clustered with acidic residues and forms the narrowest opening at the bottom of the funnel with a diameter of about 12 Å, wide enough for free ion passage (Fig. 3e, f and Extended Data Fig. 8 ). The α1 helix is located in the C-terminal region of an exceptionally long S1 helix and, consequently, the luminal canopy is firmly supported by four pillar-like S1 helices over the transmembrane channel with a wide gap, creating an open central court just above the filter with four side windows (Figs 1b and 3f , g) that provide additional luminal ion passages to the ion conduction pore. The open central court is surrounded by an exceptionally large number of acidic residues from the luminal pore loop and the luminal entrance to the filter, creating a highly negative environment (Fig. 3f, g) . This feature, along with multiple converging ion passages, renders the central court an electrostatic sink that can favourably attract divalent Ca 2+ ions. The enrichment of Ca 2+ ions can effectively limit the access of monovalent cations to the filter and, thereby, reduce the permeation of monovalent ions. Indeed, it has been shown that neutralizing the acidic residues on the luminal pore loop weakens the Ca 2+ blockage 22 .
The density of the S4-S5 linker in the overall TRPML1 structure is poorly resolved, indicating dynamic motion of the linker. A focused classification at the transmembrane region yielded two subsets of particles that were reconstructed individually into two structures at 3.64 Å and 3.75 Å resolution, respectively, each adopting a distinct conformation at the S4-S5 linker (Extended Data Fig. 3 ). The nearly equal distribution of particles for the two structures (9,000 and 11,000 particles, respectively) suggests that the unliganded TRPML1 channel is stable in two closed states (closed I and II), with the S4-S5 linker undergoing conformational equilibrium.
The S4-S5 linker adopts a straight helix in the closed I state, with its N terminus interacting with the S5 helix from the neighbouring subunit ( Fig. 4a-c) . Four linker helices surround the S6 bundle crossing and stabilize the closed channel pore. It is notable that several gain-of-function mutations similar to the Val432Pro varitint-waddler phenotype 15, [27] [28] [29] have been identified on S5 in a proline-scanning mutagenesis study 30 , including Arg427Pro, Cys430Pro and Cys431Pro, which are all clustered at the interaction interface between S5 and the S4-S5 linker (Fig. 4c ). These mutations probably cause a kink in the S5 helix, disrupt the inter-subunit interactions and destabilize the closed channel pore. In the closed II state, the S4-S5 linker undergoes a marked conformational change as compared to the closed I state (Fig. 4a, b ). Pivoting at its C terminus, the linker swings away from the central axis and unlocks the cuff around the bundle crossing; the N-terminal half of the linker helix becomes partially unfolded and bulges outward, and the H3-turn-H4 extension of S2/S3 moves slightly towards the centre and engages in direct contact with the bulged linker that is not observed in the closed I state (Fig. 4d ). Whereas the S6 inner helices remain in a closed state, the outward movement of the S4-S5 linker starts to pull S5 away from the central axis, and any further movement of S5 would result in a concurrent movement of S6 and pore opening. Therefore, the closed II structure probably represents a transition state in which the channel is primed for opening. As the S4-S5 linker is strategically positioned to couple the voltageor ligand-induced conformational changes to the opening of the pore in various six-transmembrane channels, it probably has a similar role in PtdInsP 2 gating of TRPML1. With its binding site at the N terminus of TRPML1, distal from the S4-S5 linker, PtdIns(3,5)P 2 activation is likely to be mediated by the H3-turn-H4 of the S2/S3 extension, in which the H3 helix interacts with H1 and the H4 helix interacts with the bulged S4-S5 linker in the closed II state. We therefore propose a simple gating mechanism, in which the PtdIns(3,5)P 2 -induced conformational change can be propagated to the outward-bulged S4-S5 linker via the H3-turn-H4 and open the pore (Fig. 4e) . This model implies that PtdIns(3,5)P 2 activation can occur only when TRPML1 is in the closed II transition state, as the S4-S5 linker helix is decoupled from H3-turn-H4 in the closed I state, and thereby the linker transition between the two closed states is a prerequisite for the PtdInsP 2 activation of TRPML.
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MethOdS Data reporting. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Protein expression, purification and nanodisc reconstitution. Mouse TRPML1 (NCBI RefSeq NM_053177.1) containing a C-terminal thrombin cleavage site followed by a 10× His tag was cloned into a pEZT vector 31 and heterologously expressed in HEK293F cells (Life Technologies) using the BacMam system (Thermo Fisher Scientific). The baculovirus was generated in Sf9 cells (Life Technologies) following the standard protocol and used to infect HEK293F cells at a ratio of 1:40 (virus:HEK293F, v/v) and supplemented with 2 mM sodium butyrate to boost protein expression. Cells were cultured in suspension at 37 °C for 48 h and collected by centrifugation at 3,000g. All purification procedures were carried out at 4 °C unless specified otherwise. The cell pellet was re-suspended in buffer A (50 mM Tris pH 8.0, 200 mM NaCl) supplemented with a protease inhibitor cocktail (containing 1 mg ml −1 each of DNase, pepstatin, leupeptin, and aprotinin and 1 mM PMSF) and homogenized by sonication on ice. Mouse TRPML1 was extracted with 1% (w/v) n-dodecyl-β-d-maltopyranoside (DDM; Anatrace) supplemented with 0.02% (w/v) cholesteryl hemisuccinate (CHS; Sigma-Aldrich) by gentle agitation for 2 h. After extraction, the supernatant was collected after a 40-min centrifugation at 48,000g and incubated with Ni-NTA resin (Qiagen) using gentle agitation. After 2 h, the resin was collected on a disposable gravity column (Bio-Rad), washed with buffer B (buffer A + 0.1% DDM + 0.02% CHS) with 20 mM imidazole, and then buffer B. The washed resin was left on-column in buffer B and digested with thrombin (Roche) overnight. After thrombin digestion, the flow-through containing untagged MmTRPML1 was collected, concentrated, and purified by size-exclusion chromatography on a Superose 6 10/300 GL column (GE Heathcare) pre-equilibrated with buffer C (20 mM Tris pH 8.0, 150 mM NaCl, 0.1% DDM, 0.02% CHS). The protein peak was collected, concentrated to 40 μM and reconstituted into lipid nanodiscs following the published protocol 24 . In brief, MSP1, TRPML1, and lipid (POPC:POPG:POPE = 3:1:1) were mixed at a molar ratio of 4:1:10 respectively, and incubated on ice for 30 min. Detergents were removed by adding Bio-Beads SM2 (Bio-Rad) to a concentration of 100 mg ml −1 followed by gentle agitation. The Bio-Beads were replaced with fresh ones every 4 h, twice in total. After detergent removal, the sample was loaded onto a Superose 6 10/300 GL column pre-equilibrated with buffer D (20 mM Tris pH 8.0 and 150 mM NaCl) and the elution peak corresponding to the reconstituted TRPML1 was collected for electron cryo-microscopy analysis. Electron microscopy data acquisition. The cryo-EM grids were prepared by applying 3 μl of mouse TRPML1 in nanodiscs (1.3 mg ml −1 ) to a glow-discharged Quantifoil R1.2/1.3 200-mesh copper holey carbon grid (Quantifoil, Micro Tools GmbH) and blotted for 4.0 s under 100% humidity at 4 °C before being plunged into liquid ethane using a Mark IV Vitrobot (FEI). Micrographs were acquired on a Titan Krios microscope (FEI) operated at 300 kV with a K2 Summit direct electron detector (Gatan), using a slit width of 20 eV on a GIFQuantum energy filter. EPU software (FEI) was used for automated data collection following standard FEI procedure. A calibrated magnification of 46,730× was used for imaging, yielding a pixel size of 1.07 Å on images, with the defocus ranging from −1.2 μm to −3 μm. Each micrograph was dose-fractionated to 30 frames under a dose rate of 4 electrons per pixel per second, with a total exposure time of 15 s, resulting in a total dose of about 50 e − Å −2 . Image processing. Motion correction was performed using the MotionCorr2 program 32 , and the contrast transfer function parameters of the micrographs were estimated using the GCTF program 33 . All other steps of image processing were performed using RELION 34 . Initially, ~1,000 particles were manually picked from a few micrographs. Class averages representing projections of TRPML1 in different orientations were selected from the 2D classification of the manually picked particles, and used as templates for automatic particle picking from the full dataset of 2,974 micrographs. The extracted particles were binned 3 times and subjected to 2 rounds of 2D classification, and a total of 519,463 particles were finally selected for 3D classification and 3D refinement. For the first round of 3D classification, the TRPV1 structure (EMDB code 5778) was used as the reference. One of the 3D classes showed good secondary structural features and is markedly different from TRPV1. It was then selected as the reference for the second round of 3D classification. One of the resulting 3D reconstructions from about 71,000 particles showed improved cryo-EM density and a clear four-fold symmetry with a resolution of ~4 Å after 3D refinement using the un-binned particles (C4 symmetry imposed) and particle polishing. However, part of the transmembrane domain showed poor density, indicative of local structural heterogeneity. Therefore, we performed a focused 3D classification with density subtraction 35 in order to improve the density of the transmembrane domain. In this approach, the density corresponding to the soluble domain of the channel as well as the belt-like density from the nanodisc was subtracted from the original particles. The subsequent 3D classification on the modified particles was carried out by applying a mask around the transmembrane domain and having all of the orientations fixed at the value determined in the 3D refinement. This round of classification yielded 6 classes of particles, among which one major class (~50,000 particles) showed poor density in the transmembrane region and was discarded. After a new 3D refinement using the particles from the 5 classes (~20,000 total particles), the resolution of the map was improved from 4 Å to 3.59 Å. In addition, these 5 classes of particles can be partitioned into 2 groups with 9,000 and 11,000 particles, respectively. 3D refinement of each group yielded structures at 3.64 Å (closed I state) and 3.75 Å (closed II state) resolution, respectively, each showing distinct conformations at the S4-S5 linker. All resolutions were estimated by applying a soft mask around the protein density and the gold-standard Fourier shell correlation (FSC) = 0.143 criterion. ResMap 36 was used to calculate the local resolution map. Model building, refinement and validation. For the soluble domain, the structure of human TRPML1 I-II linker (PDB code: 5TJC) was docked into the cryo-EM map of mouse TRPML1 followed by manual adjustment and mutation of residues that differed between mouse and human TRPML1. For the transmembrane domain, de novo atomic model building was conducted in Coot 37 . Amino acid assignment was achieved based mainly on the clearly defined densities for bulky residues (Phe, Trp, Tyr, and Arg). Models were refined against summed maps using phenix.real_space_refine 38 implemented in PHENIX 39 . The model was validated using previously described methods 40 to avoid overfitting. The final structure models include residues 40-198, 215-285, and 296-527. About 40 residues at the amino terminus and 50 residues at the carboxy terminus are disordered and not modelled. The geometry statistics of the models were generated using MolProbity 41 . Pore radii were calculated using the HOLE program 42 . All the figures were prepared in PyMol 43 or Chimera 44 . Electrophysiology. By replacing the two di-leucine motifs (L 15 L and L 577 L) responsible for lysosomal targeting with alanine residues 13, 45 , mouse TRPML1 (TRPML1-4A) can be overexpressed and trafficked to the plasma membrane in HEK293 cells, allowing for direct measurement of channel activity by patching the plasma membrane. In this setting, the extracellular side is equivalent to the luminal side of TRPML1 in endosomes or lysosomes. The constitutively active V432P mutant, equivalent to the gain-of-function mutation of the mouse TRPML3 in the varitint-waddler (Va) phenotype 15, [27] [28] [29] , can be trafficked to the plasma membrane without replacing the di-leucine motifs, and therefore V432P and V432P/ D472N mutants were both constructed on the background of the wild-type channel. The N-terminal truncation mutant was constructed on the background of TRPML1-4A. DNA fragments encoding mouse TRPML1 and its mutants were cloned into a pEGFP-C2 vector using XhoI and SacII restriction sites, as described 2 . N-terminal eGFP-tagged mouse TRPML1 or its mutant were expressed in HEK293 cells grown in a six-well tissue culture dish by transiently transfecting 2 μg of DNA plasmid using Lipofectamine 2000 (Thermo Fisher Scientific). Then, 24 to 48 h after transfection, cells were dissociated by trypsin treatment and kept in complete serum-containing medium; the cells were re-plated onto 35 mm tissue culture dishes and kept in a tissue culture incubator until recording. Patch clamp in the whole-cell or inside-out configuration was used to measure TRPML1 activity on the HEK plasma membrane. The standard bath solution for whole-cell current recording contained (in mM): 145 sodium methanesulfonate, 5 NaCl, 1 MgCl 2 , 1 CaCl 2 or nominal Ca 2+ free, 10 HEPES buffered with Tris, pH 7.4, or 10 MES buffered with Tris, pH 4.6; and the pipette solution contained (in mM): 140 caesium methanesulfonate, 5 NaCl, 5 MgCl 2 , 10 EGTA, 10 HEPES buffered with Tris, pH 7.4. For the measurement of luminal Ca 2+ -concentration-dependent blockage, the bath solution contained (in mM): 145 sodium methanesulfonate, 5 NaCl, 1 MgCl 2 , 10 HEPES buffered with Tris, pH 7.4, with 0.5 EGTA for 0 Ca 2+ , or 0.1, 1, 10 Ca 2+ without EGTA. The bath solution for inside-out configuration contained (in mM): 140 potassium methanesulfonate, 5 NaCl, 2 MgCl 2 , 0.4 CaCl 2 , 1 EGTA, 10 HEPES buffered with Tris, pH 7.4; and the pipette solution contained (in mM): 145 sodium methanesulfonate, 5 NaCl, 1 MgCl 2 , 0.5 EGTA, 10 MES buffered with Tris, pH 4.6. The patch pipettes were pulled from Borosilicate glass (Harvard Apparatus) and heat polished to a resistance of 2-5 MΩ (2-3 MΩ for inside-out patch, and 3-5 MΩ for whole-cell current recoding). Data were acquired using an AxoPatch 200B amplifier (Molecular Devices) and a low-pass analogue filter set to 1 kHz. The current signal was sampled at a rate of 20 kHz using a Digidata 1322A digitizer (Molecular Devices) and further analysed with pClamp 9 software (Molecular Devices). After the patch pipette attached to the cell membrane, the giga seal (5-10 GΩ) was formed by gentle suction. The whole-cell configuration was formed by short zap or suction to rupture the patch. The holding potential was set to 0 mV. The whole-cell and inside-out macroscopic current recordings were obtained using voltage pulses ramped from −140 mV to +50 mV over a duration of 800 ms. The sample traces for single-channel recording or the I-V curves of 
